Harmony Biosciences Holdings (HRMY) Return on Assets (2020 - 2026)
Harmony Biosciences Holdings (HRMY) reported Return on Assets of 0.0% for Q1 2026, little changed on a YoY basis from 0.0% in Q1 2025, and down 8.83% sequentially from 0.0% in Q4 2025.
Harmony Biosciences Holdings (HRMY) Return on Assets (2020 - 2026) Analysis & Trends
Harmony Biosciences Holdings (HRMY) has 7 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.
- For the quarter ending Q1 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
- Return on Assets slipped to 0.0% in Q1 2026, from 0.0% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2022 to a low of 0.0% in Q1 2022.
- A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Assets.
- Peak annual rise in Return on Assets reached 0 bps in 2022, while the deepest fall reached 0 bps in 2022.
- Tracing HRMY's Return on Assets over 5 years: stood at 0.0% in 2022, then slumped by 41 bps to 0.0% in 2023, then declined by 7 bps to 0.0% in 2024, then grew by 8 bps to 0.0% in 2025, then retreated by 9 bps to 0.0% in 2026.
- Business Quant data shows HRMY's Return on Assets at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.69% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.01% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -0.80% |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 0.00% |
| 10 | Harmony Biosciences Holdings | 2.07 Bn | 1.55 Bn | 170.88 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |